March 30, 2023 Thesis Open Access

ASEFE, BIRHAN

DCAT Export

<?xml version='1.0' encoding='utf-8'?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:adms="http://www.w3.org/ns/adms#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dct="http://purl.org/dc/terms/" xmlns:dctype="http://purl.org/dc/dcmitype/" xmlns:dcat="http://www.w3.org/ns/dcat#" xmlns:duv="http://www.w3.org/ns/duv#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:frapo="http://purl.org/cerif/frapo/" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:gsp="http://www.opengis.net/ont/geosparql#" xmlns:locn="http://www.w3.org/ns/locn#" xmlns:org="http://www.w3.org/ns/org#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:prov="http://www.w3.org/ns/prov#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:schema="http://schema.org/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:vcard="http://www.w3.org/2006/vcard/ns#" xmlns:wdrs="http://www.w3.org/2007/05/powder-s#">
  <rdf:Description rdf:about="https://doi.org/10.20372/nadre:8316">
    <rdf:type rdf:resource="http://www.w3.org/ns/dcat#Dataset"/>
    <dct:type rdf:resource="http://purl.org/dc/dcmitype/Text"/>
    <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://doi.org/10.20372/nadre:8316</dct:identifier>
    <foaf:page rdf:resource="https://doi.org/10.20372/nadre:8316"/>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>ASEFE, BIRHAN</foaf:name>
        <foaf:givenName>BIRHAN</foaf:givenName>
        <foaf:familyName>ASEFE</foaf:familyName>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Woldia University</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:title>PREVALENCE OF OPPORTUNISTIC INFECTIONS AND ASSOCIATED FACTORS AMONG HIV-INFECTED ADULTS ON ANTIRETROVIRAL THERAPY IN WOLDIA COMPREHENSIVE SPECIALIZED HOSPITAL, NORTH WOLLO, ETHIOPIA, 2023</dct:title>
    <dct:publisher>
      <foaf:Agent>
        <foaf:name>Zenodo</foaf:name>
      </foaf:Agent>
    </dct:publisher>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#gYear">2023</dct:issued>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2023-03-30</dct:issued>
    <owl:sameAs rdf:resource="https://nadre.ethernet.edu.et/record/8316"/>
    <adms:identifier>
      <adms:Identifier>
        <skos:notation rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://nadre.ethernet.edu.et/record/8316</skos:notation>
        <adms:schemeAgency>url</adms:schemeAgency>
      </adms:Identifier>
    </adms:identifier>
    <dct:relation rdf:resource="https://hdl.handle.net/N/A"/>
    <dct:isVersionOf rdf:resource="https://doi.org/10.20372/nadre:8315"/>
    <dct:isPartOf rdf:resource="https://nadre.ethernet.edu.et/communities/wu"/>
    <dct:isPartOf rdf:resource="https://nadre.ethernet.edu.et/communities/zenodo"/>
    <dct:description>&lt;p&gt;Introduction &amp;ndash; Opportunistic infections are infections occurring due to bacteria, fungi, viruses, or parasites that normally do not cause a disease, but become pathogenic when the body&amp;#39;s defense system is impaired. Opportunistic infections associated with HIV infections are lower the quality of life of HIV infected persons, speed up the rate of progression to AIDS, reduce patients&amp;rsquo; response to treatment and are usually associated with high medical care costs and the leading cause of morbidity and mortality among HIV/AIDS patients. However, studies regarding the magnitude of opportunistic infections in HIV-infected adults on ART are very limited.&lt;br&gt; Objective - To assess the prevalence of opportunistic infections and its associated factors among HIV- infected adults on anti-retroviral therapy attending Woldia comprehensive specialized hospital.&lt;br&gt; Methods - Institution based cross sectional study was conducted among 405 HIV-infected adults from January 16, 2023 to February 16, 2023. A structured pre-tested interviewer administered questionnaire was used to collect data. The study participants were selected by the systematic sampling technique. All variables with p-value of &amp;le; 0.25 in binary logistic regression were taken into multivariable model. Crude and adjusted odds ratios with their 95% confidence intervals were calculated and variables having p value &amp;le; 0.05 in the multivariate analysis were taken as significant predictors.&lt;br&gt; Results: A total of 405 HIV-infected adults on antiretroviral therapy participated in this study with a response rate of 100%. The overall prevalence of opportunistic infections among HIV/AIDS patients on ART was 42.2% (95% CI; 37.4 - 47.2). The highest rates of OIs observed were tuberculosis (TB) (27.5%), followed by herpes zoster (25.2%), chronic diarrhea 15.2% and oral and/or esophageal thrush 14.04%. Age between 30-39 (AOR=3.46; 95% CI=1.78, 6.73), 40-49 years (AOR= 2.47; 95% CI, 1.21, 5.04), &amp;gt;= 50 years ( 3.09; 95% CI, 1.19, 8.03), being on WHO clinical stage III ( AOR= 4.63; 95% CI, 2.67, 8.04), Stage IV (AOR=6.63; 95% CI=3.29, 13.35), having CD4 count &amp;lt;= 200 cells/mm3 (AOR=1.91; 95%CI = 1.15, 3.18), chat chewers (AOR= 1.72;95% CI= 1.07, 2.76) and being ambulatory ( AOR= 2.18;95%CI; 1.02, 4.63) were predictors of opportunistic infections.&lt;br&gt; Conclusion: In this study, a high rate of OIs was observed compared with previous studies. Age of respondents, chat chewing, WHO clinical stage III and IV, CD4 count less than or equal to 200 cells/mm3 and being ambulatory were found to be predictors of OIs. More attention should be given to those who have low CD4 count and advanced WHO clinical staging.&lt;br&gt; Key words: Opportunistic infection, HIV infected patients, ART, Woldia comprehensive specialized hospital&lt;/p&gt;</dct:description>
    <dct:accessRights rdf:resource="http://publications.europa.eu/resource/authority/access-right/PUBLIC"/>
    <dct:accessRights>
      <dct:RightsStatement rdf:about="info:eu-repo/semantics/openAccess">
        <rdfs:label>Open Access</rdfs:label>
      </dct:RightsStatement>
    </dct:accessRights>
    <dcat:distribution>
      <dcat:Distribution>
        <dct:rights>
          <dct:RightsStatement rdf:about="http://www.opendefinition.org/licenses/cc-by">
            <rdfs:label>Creative Commons Attribution</rdfs:label>
          </dct:RightsStatement>
        </dct:rights>
        <dcat:accessURL rdf:resource="https://doi.org/10.20372/nadre:8316"/>
      </dcat:Distribution>
    </dcat:distribution>
    <dcat:distribution>
      <dcat:Distribution>
        <dcat:accessURL rdf:resource="https://doi.org/10.20372/nadre:8316"/>
        <dcat:byteSize>751421</dcat:byteSize>
        <dcat:downloadURL rdf:resource="https://nadre.ethernet.edu.et/record/8316/files/Birhan Asefe_General MPH_Health Sciences 2016 E.C Graduat.pdf"/>
        <dcat:mediaType>application/pdf</dcat:mediaType>
      </dcat:Distribution>
    </dcat:distribution>
  </rdf:Description>
</rdf:RDF>